FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $2.18 billion.
On a per-share basis, the Foster City, California-based company said it had net income of $1.74. Earnings, adjusted for one-time gains and costs, came to $1.86 per share.
The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.83 per share.
The HIV and hepatitis C drugmaker posted revenue of $7.93 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $7.57 billion.
Gilead expects full-year earnings in the range of $8.45 to $8.85 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
/Cisco%20Systems%2C%20Inc_%20HQ-by%20Sundry%20Photography%20via%20iStock.jpg)
